Sektor Newron Pharmaceuticals S.p.A.

Aktien

A0LF18

IT0004147952

NWRN

Biotechnologie

Markt geschlossen - Swiss Exchange 17:30:59 14.02.2025 % 5 Tage % 1. Jan.
10.12 CHF -1.75% Intraday Chart für Newron Pharmaceuticals S.p.A. +4.12% +13.07%
Hauptkonkurrenten
Zu einer Liste hinzufügen
% % 5 Tage Veränderung - 1 Monat Veränderung - 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 J. Veränd. 5 J. Veränd. 10 J. Kap.($)
-1.75%+4.12%+13.58%+32.98%+13.07%+17.95%+622.86%+48.82%-61.08% 225 Mio.
-0.43%-1.39%+10.79%+6.55%+11.12%+28.71%-1.26%+42.82%+440.29% 47.89 Mrd.
-1.33%-7.06%-2.28%-4.68%-1.56%-20.55%-19.37%+17.72%+205.54% 34.06 Mrd.
-0.45%-1.71%-3.21%+13.07%-5.12%-0.38%+22.57%+13.23%+311.71% 26.65 Mrd.
+0.04%+6.58%+1.61%-4.06%+5.03%+72.82%+82.70%+255.68%+145.24% 16.54 Mrd.
+1.95%-3.75%-7.01%-6.90%-11.21%-36.39%-27.22%+6.24%+210.30% 15.37 Mrd.
+6.79%+29.70%+180.99%+57.94%+164.93% - - - - 14.08 Mrd.
+3.35%+1.20%-4.27%-17.05%-20.66%-61.62%-76.84%+73.63% - 12.7 Mrd.
-1.12%-9.44%-11.76%-9.10%-8.45%-5.96%-36.23%+26.49%+178.79% 10.42 Mrd.
-0.65%-3.93%+2.80%+1.59%+2.39%-12.73%+95.24%+247.61% - 10.36 Mrd.
-0.47%-3.56%-14.94%-7.91%-12.95%-9.60%-21.65%+1.24%+52.90% 8.62 Mrd.
-0.77%-7.20%-14.65%-22.81%-17.67%-37.99%-53.58%-13.88%+106.48% 7.77 Mrd.
-1.57%-3.60%+2.11%-29.11%-7.02%+36.84%+92.75%+43.66% - 7.52 Mrd.
-1.05%+4.89%+6.20%-21.98%-3.44%+23.22%-40.47%-32.95%+269.67% 6.14 Mrd.
-.--%-.--% - - - - - - - 6.07 Mrd.
-1.58%-1.42%+4.96%-16.22%-0.31%+21.59%-45.35%-1.44% - 6.05 Mrd.
-1.31%-10.52%-8.40%-1.79%+7.70%+22.32%+15.33%+40.25% - 6 Mrd.
-0.31%+13.68%+25.93%+26.60%+24.79%+28.22%+55.57%+101.97%-49.73% 5.84 Mrd.
-0.15%-6.49%+8.41%+18.20%+10.04%+137.34%+343.93%+1’551.22% - 5.8 Mrd.
+2.27%-1.15%-5.05%-16.63%-11.21%-36.74%-4.76%-48.38%-51.39% 4.9 Mrd.
Durchschnitt -0.32%-0.21%+9.78%-0.07%+7.34%+9.28%+55.79%+131.88%+146.56% 12.65 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung -0.30%-0.51%+10.70%+1.33%+8.60%+6.12%+11.01%+89.06%+250.91%
Biotechnologie und medizinische Forschung - Andere
  1. Börse
  2. Aktien
  3. A0LF18 Aktie
  4. Sektor Newron Pharmaceuticals S.p.A.